The objective is to establish consensus on and provide emerging good practices for conducting, reporting and evaluating data quality of electronic health records (EHRs) for health technology assessments (HTAs), including a data quality checklist for use of EHR-derived real-world data (RWD). The task force will build on the frameworks and approaches under development across HTA agencies, as well as on the richer data quality standards literature that has been more focused on regulatory decision making.


This topic is of high interest in the HEOR community and across geographies, given the inexorable increase of digital data across the globe. Currently, there are no fully developed frameworks for HTA use, including a lack of attention on resource use derived from RWD that informs costs and budget impact analyses. These data may need to be evaluated and assessed differently from clinical data informing effectiveness. The task force will explore this in detail and report recommendations for different types of uses, such as clinical effectiveness or resource use. The patient perspective in the study design, outcome selection has been recognized of increasing importance and we will include a section on patient-centeredness in the final report.


Rachael Fleurence, PhD

Senior Advisor, National Institutes of Health
Bethesda, MD, United States

Scott Ramsey, PhD, MD

Full Member & Co-Director, Fred Hutchinson Cancer Research Center
Lake Forest Park, WA, United States

Leadership Group

Blythe Adamson, PhD, MPH

Principal Scientist, Flatiron Health
New York, NY, United States

Ran Balicer, PhD, MD

Chief Innovation Officer, Clalit Health Services
Tel Aviv, Israel

Elsa Bouee Benhamiche, MS, PharmD, MPH

Project manager, Institut national du cancer
Boulogne Billancourt, 92, France

Jon Campbell, PhD

Chief Science Officer, National Pharmaceutical Council
Washington, DC, United States

Sebastian Garcia Marti, MSc, MD

HTA and Health Economics Coordinator, IECS - Institute for Clinical Effectiveness
C.A.B.A., Argentina

Kevin Haynes, MS, PharmD

Associate Director of Epidemiology, Janssen Research and Development, LLC
Wayne, PA, United States

Seamus Kent, MSc, PhD

Assistant Professor, Erasmus University Rotterdam
Rotterdam, ZH, Netherlands

Patrick Muller, MSc, PhD

National Institute for Health and Care Excellence (NICE)
London, LON, United Kingdom

Joseph Ross, MD, MHS

Professor of Medicine and Public Health, Yale University
New Haven, CT, United States

James Tcheng, MD

Professor of Medicine & Professor of Family Medicine and Community Health (Informatics), Duke University School of Medicine
Durham, NC, United States
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now